Filter posts

FOX Business: BIO CEO Jim Greenwood Discusses Future of Medicine

BIO President and CEO Jim Greenwood appeared on Fox Business during the 17th Annual BIO …

Nasdaq Social Bell: Twitter Strategies For Biotechs

Last week at the BIO CEO & Investor Conference in New York City, I had …

Plenary Sessions Announced for the 12th Annual BIO Asia International Conference

This year’s BIO Asia International Conference has tripled the educational programming content to offer a …

Deal Structures: More Options for Companies

By most measures, 2014 was a great year for the biotechnology industry. Venture capital deal …

Fireside Chats with Five CEOs Featured at Day Two of the BIO CEO & Investor Conference

Fireside Chat with John F. Milligan, PhD, President & COO, Gilead Sciences The first fireside …

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, …

Ten Years of Therapeutic Venture Capital

What therapeutic areas have received the most funding in private drug companies over the last …

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

Digital health has the potential to improve the life science industry by combining traditional and …

Producing "21st Century Cures" - 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman …

BIO CEO & Investor Conference Kicks Off in NYC

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering …